| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 01.06.21 | AAC Clyde Space - Progress as consolidation phase commences | 481 | Edison Investment Research | AAC Clyde Space has delivered a strong Q121 with revenue growth of 55% and a substantial reduction in EBITDA losses. The ongoing activities continued to develop, positively augmented by initial contributions... ► Artikel lesen | |
| 01.06.21 | Fidelity China Special Situations - Seeking out and capitalising on structural winners | 258 | Edison Investment Research | Fidelity China Special Situations (FCSS) aims to deliver long-term capital growth from a portfolio of stocks listed mainly in China and Chinese companies listed abroad. Manager Dale Nicholls focuses... ► Artikel lesen | |
| 01.06.21 | Borussia Dortmund - Nice finish | 598 | Edison Investment Research | Borussia Dortmund's Q321 results reflected ongoing cost control, while COVID continued to affect attendance-related revenues. The team's late surge to finish third in the Bundesliga, and more silverware... ► Artikel lesen | |
| 01.06.21 | Nynomic - Growth in a time of coronavirus | 445 | Edison Investment Research | Demand for Nynomic's smart, miniaturised measurement technology is benefitting from the new automated production methodologies often referred to as industry 4.0. Revenue growth in FY20 and FY21 is supported... ► Artikel lesen | |
| 01.06.21 | Ergomed - What's next after stellar 2020 performance? | 293 | Edison Investment Research | Although most of 2020 was challenging for the contract research outsourcing (CRO) sector, for Ergomed it was a transformative growth period due to well-balanced pharmacovigilance (PV) and CRO offerings.... ► Artikel lesen | |
| 01.06.21 | AlzeCure Pharma - Catalysts on the horizon | 305 | Edison Investment Research | AlzeCure remains on track with its evolution into a mid-stage biotech, having recently reported positive headline data from its Phase Ib trial for ACD440, topical TRPV1 antagonist for pain. The company... ► Artikel lesen | |
| 01.06.21 | Medlab Clinical - Novel drug delivery and synthetic cannabinoids | 233 | Edison Investment Research | Medlab is a drug delivery biotechnology company with a proprietary platform, NanoCelle, which is a patented nanomicellar formulation that can improve the delivery of drugs. With the growing appreciation... ► Artikel lesen | |
| 01.06.21 | Datagroup - Back on track | 718 | Edison Investment Research | After a difficult FY20, IT services provider DATAGROUP's earnings recovered in H121, driven by a turnaround in its Financial IT Services (FIS) unit, which took a hit in FY20. The M&A-driven business... ► Artikel lesen | |
| 01.06.21 | Thin Film Electronics - Happy first anniversary of microbattery strategy | 288 | Edison Investment Research | Q121 marks the first anniversary of Thin Film Electronics' (Thinfilm) strategic pivot to commercialising its proprietary ultra-thin solid-state microbattery product for applications such as hearing... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 13.427 |
| TESLA | 5.022 |
| DEUTSCHE BANK | 4.039 |
| NVIDIA | 3.782 |
| META PLATFORMS | 3.651 |
| TUI | 2.902 |
| SUPER MICRO COMPUTER | 2.448 |
| AIXTRON SE | 2.418 |
| NEL | 2.346 |
| BAYER | 2.173 |
| RHEINMETALL | 2.159 |
| BASF | 2.093 |
| VARTA | 2.086 |
| INFINEON | 1.703 |
| RENK GROUP | 1.647 |
| BYD | 1.485 |
| MICROSOFT | 1.471 |
| COMMERZBANK | 1.431 |
| PLUG POWER | 1.410 |
| ALPHABET | 1.263 |
| AMAZON | 1.118 |
| HELLOFRESH | 1.088 |
| DEUTSCHE LUFTHANSA | 1.067 |
| RWE | 1.061 |
| THYSSENKRUPP | 1.047 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
